Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

NARecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Gastric LesionGastric Precancerous ConditionGastric Cancer
Interventions
PROCEDURE

Additional blood collection as part of a blood sampling performed during routine care or specific for the research if not part of routine care.

Collection of an additional blood volume (9 mL) as part of a blood sampling performed during routine care or specific for the research if not part of routine care.

PROCEDURE

Blood collection

Blood sample collection (10 mL)

Trial Locations (8)

Unknown

COMPLETED

Ambroise Paré Teaching Hospital (AP-HP), Boulogne-Billancourt

RECRUITING

Beaujon Teaching Hospital (AP-HP), Clichy

RECRUITING

Kremlin Bicêtre Teaching Hospital (AP-HP), Le Kremlin-Bicêtre

RECRUITING

Cochin Teaching Hospital (AP-HP), Paris

RECRUITING

INVOLvE - Investigation et volontaires en santé humaine (Institut Pasteur), Paris

RECRUITING

Saint Antoine Teaching Hospital (AP-HP), Paris

NOT_YET_RECRUITING

Saint Antoine Teaching Hospital (AP-HP), Paris

NOT_YET_RECRUITING

Saint Louis Teaching Hospital (AP-HP), Paris

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

lead

Institut Pasteur

INDUSTRY

NCT05854368 - Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer | Biotech Hunter | Biotech Hunter